These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32098730)

  • 21. Associations of multimorbidity and patient-reported experiences of care with conservative management among elderly patients with localized prostate cancer.
    Fiano RM; Merrick GS; Innes KE; Mattes MD; LeMasters TJ; Shen C; Sambamoorthi U
    Cancer Med; 2020 Aug; 9(16):6051-6061. PubMed ID: 32628817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Case Volume and Facility Complexity Level Associated With Postoperative Complications After Hip Fracture Surgery in the Veterans Affairs Healthcare System?
    Wong JK; Kim TE; Mudumbai SC; Memtsoudis SG; Giori NJ; Howard SK; Oka RK; King R; Mariano ER
    Clin Orthop Relat Res; 2019 Jan; 477(1):177-190. PubMed ID: 30179946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer.
    Spencer BA; Fung CH; Wang M; Rubenstein LV; Litwin MS
    J Urol; 2004 Dec; 172(6 Pt 1):2362-5. PubMed ID: 15538268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
    Cooperberg M; Lubeck DP; Penson D; Mehta SS; Carroll PR; Kane CJ
    J Urol; 2003 Sep; 170(3):905-8. PubMed ID: 12913727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-Value Prostate Cancer Screening Among Older Men Within the Veterans Health Administration.
    Radomski TR; Huang Y; Park SY; Sileanu FE; Thorpe CT; Thorpe JM; Fine MJ; Gellad WF
    J Am Geriatr Soc; 2019 Sep; 67(9):1922-1927. PubMed ID: 31276198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022.
    Nik-Ahd F; De Hoedt A; Butler C; Anger JT; Carroll PR; Cooperberg MR; Freedland SJ
    JAMA; 2023 Jun; 329(21):1877-1879. PubMed ID: 37119522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.
    Tosoian JJ; Mamawala M; Patel HD; Alam R; Epstein JI; Ross AE; Carter HB
    J Urol; 2018 Apr; 199(4):954-960. PubMed ID: 29074222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing Utilization of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.
    Fam MM; Yabes JG; Macleod LC; Bandari J; Turner RM; Lopa SH; Furlan A; Filson CP; Davies BJ; Jacobs BL
    Urology; 2019 Aug; 130():99-105. PubMed ID: 30940480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
    Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
    Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.
    Ahuja V; Sohn MW; Birge JR; Syverson C; Budiman-Mak E; Emanuele N; Cooper JM; Huang ES
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1214-34. PubMed ID: 26679970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.
    Daskivich TJ; Thomas IC; Luu M; Shelton JB; Makarov DV; Skolarus TA; Leppert JT
    J Urol; 2019 Sep; 202(3):518-524. PubMed ID: 31009286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active surveillance in intermediate-risk prostate cancer.
    Klotz L
    BJU Int; 2020 Mar; 125(3):346-354. PubMed ID: 31647166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice-Level Adoption of Conservative Management for Prostate Cancer.
    Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
    J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overuse of Cystoscopic Surveillance Among Patients With Low-risk Non-Muscle-invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors.
    Han DS; Lynch KE; Chang JW; Sirovich B; Robertson DJ; Swanton AR; Seigne JD; Goodney PP; Schroeck FR
    Urology; 2019 Sep; 131():112-119. PubMed ID: 31145947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS).
    Bratt O; Holmberg E; Andrén O; Carlsson S; Drevin L; Johansson E; Josefsson A; Nyberg M; Sandberg J; Stattin P; Robinsson D
    Eur Urol; 2019 Oct; 76(4):461-466. PubMed ID: 30878303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health care delivery system contributions to management of newly diagnosed prostate cancer.
    Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
    Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer.
    Mazur DJ; Merz JF
    J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between sexual function and prostate cancer risk in US veterans.
    Zapata DF; Howard LE; Frank J; Simon RM; Hoyo C; Grant DJ; Freedland SJ; Vidal AC
    Asian J Androl; 2017; 19(2):191-195. PubMed ID: 27586025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.